Liste der von der FDA zugelassenen Stammzelltherapien in 2022, 2023
Liste der von der FDA zugelassenen Stammzelltherapien in 2022 ALLOCORD (HPC, Nabelschnurblut), SSM Cardinal Glennon Children’s Medical Center. “For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that Mehr lesen










